PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
August 22, 2019Acta Microbiologica et Immunologica Hungarica49 citationsOpen Access

Carbapenem resistance in Escherichia coli and Klebsiella pneumoniae among Indian and international patients in North India

View Full Paper
NJNamita JaggiNCNirupama ChatterjeeVSVyoma Singh

Key Points

Key points are not available for this paper at this time.

Abstract

The aim of the study was to find out the carbapenem resistance rate and prevalence of different carbapenemase genes in Klebsiella pneumoniae and Escherichia coli from a North Indian corporate hospital that receives both Indian and international patients. A total of 528 clinical isolates of E. coli and K. pneumoniae were included in the study. All isolates that were found resistant to carbapenems by MIC testing (Vitek II Compact®) were screened for NDM, OXA-48, VIM, and KPC genes by PCR. Sequencing of NDM gene and transmissibility by conjugation assay were checked on 22 randomly selected NDM-positive isolates. One hundred and fifty-six isolates (29.54%) were carbapenem-resistant. The rate of carbapenem resistance was significantly higher in K. pneumoniae as compared to E. coli (53.9% vs. 15.6%; p E. coli than K. pneumoniae (p . All the tested isolates formed transconjugants and NDM-5 was the most common variant in both species (15/22). The presence of plasmid-based NDM calls for stricter surveillance measures in our hospital settings.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Jaggi et al. (2019) studied this question.

synapsesocial.com/papers/69d7ebc605ee2ba81dbee8fchttps://doi.org/10.1556/030.66.2019.020
Ask AI
Helpful
Bookmark
Share
View Full Paper